Atai Life Sciences Buy Recommendation with Attractive Price Target
+7.02%current return
"There's a company I'm not familiar with, but it definitely was on the move today. The company is called Atai Life Sciences. The ticker is ATI. The stock jumped by 11% today. This is a clinical trial stage biopharmaceutical company. It came after a Republican state senator in North Carolina said that the state could "lead the nation in expanding military veterans access to mental health drugs" because this company specifically develops treatments for mental health diseases. And Nem initiated coverage of the company with a recommendation of buy and a price target of $12. Yeah. Not a company. Almost doubling today's price."
— Natalyia Kiny Javich
The transcript reveals a trade call on Atai Life Sciences (ATI), which surged 11% on the day. The catalyst mentioned is a political statement favoring mental health drug access for military veterans, and more importantly, a coverage initiation by Nem with a buy recommendation and a $12 price target, suggesting significant upside potential.
High ConvictionScore: 8.0
Stock Idea •Stock Movers • 10 days ago